Inventor
Rosy Sher
Inventor
Bridgewater, NJ, US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations40%
C07DHeterocyclic compounds40%
A61KPreparations for medical, dental or toiletry purposes15%
C07CAcyclic or carbocyclic compounds5%
PatentTitleYear
9,051,331'Substituted dihydro benzocycloalkyloxymethyl oxazolopyrimidinones, preparation and use thereof'20158,642,603'Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof'20148,501,981'CXCR2 inhibitors'20138,283,479'CXCR2 inhibitors'20128,207,181'Substituted dihydro, trihydro and tetrahydro cycloalkyloxazolopyrimidinones, preparation and use thereof'20128,053,458'Dipyrazole compounds and their use as central nervous system agents'20117,919,628'CXCR2 inhibitors'20117,777,042'N-sulfonylpipecolic acid derivative FKBP binding composition and pharmaceutical use thereof'2010Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2010–2011Patents assigned to AVENTIS PHARMA INC (2)· patent assignee history
2010–2015Based in Bridgewater, NJ, US· patent location history
2012–2015Patents assigned to SHER ROSY (5)· patent assignee history
2012–2015Patents assigned to SANOFI SA (4)· patent assignee history
2012–2013Patents assigned to DEDIO JUERGEN (2)· patent assignee history
2012–2013Patents assigned to GRUENEBERG SVEN (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SHER ROSYself | 5 | 2012–2015 |
| SANOFI SA | 4 | 2012–2015 |
| AVENTIS PHARMA INC | 2 | 2010–2011 |
| DEDIO JUERGEN | 2 | 2012–2013 |
| GRUENEBERG SVEN | 2 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Bridgewater, New Jersey, US | 8 | 2010–2015 |